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1.  Introduction 
Competition in healthcare is a contentious subject and the EU’s role in this adds to the 
controversy insofar as questions are raised of national versus EU competence, and social 
versus economic aims. Both questions have clear relevance to discussions of the future of EU 
health law and policy. In this article we examine landmark case law emanating from the Court 
of Justice of the European Union (CJEU), the General Court and the European Commission 
in a doctrinal legal analysis to clarify the parameters of the “undertaking” concept in applying 
competition law in healthcare cases. A doctrinal legal analysis focusing on the law, rather than 
on the broader context, may appear to offer quite limited insights for an interdisciplinary 
audience. However, precisely this level of examination of the law is needed to understand 
why competition reforms in healthcare are difficult to implement at a national level. We also 
employ a comparative approach in considering the implications of EU law at national level 
regarding the Netherlands, where marketisation reforms – including mandatory private health 
insurance and liberalisation of hospital service prices – were implemented in 2006. In addition, 
a doctrinal legal analysis allows us to sketch EU level-developments from a perspective which 
may be new to a health policy audience. The methods therefore help us address the 
aforementioned questions. 
With regard to national versus EU competence, Member States are considered to have a 
certain degree of freedom in experimenting with market-based reforms, such as private sector 
delivery of healthcare services, or public-private arrangements (Andreangeli, 2016). However, 
this degree of freedom has long been deemed circumscribed: market-based reforms may have 
the unintended consequence of triggering the applicability of EU competition law (Prosser, 
2010). At EU level, the possibility of divergent interpretations by National Competition 
Authorities raises concerns about consistency at EU level, potentially creating “Euro-national 
competition rules for healthcare” (van de Gronden, 2011; van de Gronden and Szyszczak, 
2014). The need for direction and guidance to be set at EU level is also important because we 
know that England (UK) and the Netherlands – the two Member States to engage most 
actively with competition reforms of their healthcare systems – have created regimes which 
are heavily influenced by, and even borrow terminology from, EU competition law (Guy, 
2019).  
Questions of social versus economic aims emerge as the applicability of competition law to 
healthcare has featured in wider discussions of welfare state reform since the turn of the 21st 
century (e.g. Winterstein, 1999; Szyszczak, 2009; Sauter, 2013). Indeed, a recent question has 
been whether, if the healthcare sector is not fully immune from EU competition law, these 
rules can trigger the reorganisation of welfare states in the EU (van de Gronden and Rusu, 
2017). In addition to any “unintentional” triggering of EU competition law by national reforms, 
questions of applicability of EU competition law are given additional momentum at present as 
competition reforms appear reflected in a range of Country-Specific Recommendations within 
the context of the European Semester (Guy, 2019). We therefore examine here the question 
of how the “undertaking” concept of EU competition law functions in healthcare and to what 
extent it pays due consideration to healthcare-specific features. 
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In this article, we adopt a broad definition of “EU competition law” from Treaty on the 
Functioning of the European Union (TFEU) provisions encompassing both the state aid rules 
(Articles 107-109), and the prohibitions on anticompetitive agreements and abuse of 
dominance (Articles 101 and 102), described collectively as “antitrust rules”. The state aid 
regime is designed to avoid distortions of competition within the EU internal market by 
imposing on Member State governments a prohibition (subject to exceptions) on granting 
economic benefits to particular operators. EU-level cases involving the antitrust rules 
specifically in the healthcare context (as distinct from cases involving sectors such as pensions 
or education which may have implications for healthcare as well) have included the 
Commission fining professional organisations of pharmacists in France for hindering entry of 
new laboratories (Case T-90/11, ONP), and the Commission and the EU courts taking action 
against excessive pricing in the pharmaceutical sector (Hancher and Sauter, 2012; Danieli, this 
issue). We also address the partial exception to the state aid and competition rules of an 
activity being classified as a Service of General Economic Interest (SGEI). Activities classified 
as SGEI in a healthcare context include emergency patient transport services (Case C-475-
99, Ambulanz Glöckner), supplementary health insurance (Case 437/09, AG2R), the Dutch 
mandatory private health insurance scheme (Cases N541/2004 and N542/2004, 
Zorgverzekeringswet), and the Irish complementary insurance scheme (Case T-289/03, 
BUPA) (Hancher and Sauter, 2012 and van de Gronden, 2009). 
Our discussion proceeds as follows. 
Section 2 surveys EU competition law cases relating to healthcare and the parameters defining 
the “undertaking” concept up to the 2018 DZP/UZP case (Case T-216/15, Dôvera zdrvotná 
poist’ová and Union zdrvotná poist’ová) regarding Slovak health insurers. 
Section 3 takes as its starting-point the 2017 CEPPB state aid case (Case C-74/16, 
Congregación de Escuelas Pías Provincia Betania) regarding state financing of religious 
educational establishments in Spain and the three-prong test identified from the judgment (van 
de Gronden 2018) in determining the applicability of competition law which offers a new 
direction for future cases. This three-prong test is applied here to the healthcare context for 
the first time. 
Section 4 concludes with some considerations about the future of EU law and policy regarding 
competition in healthcare.  
 
2. Overview of EU case law / developing interpretations of the “undertaking” 
concept 
Although the state aid rules and “antitrust” rules are conceptually discrete,  they share a 
common starting-point: for either to be applicable, there must be an “undertaking”, long 
defined as an “economic activity” (Case C-41/90 Höfner) of “offering goods and services on 
a market” (Case 118/85 Commission v Italy). Whether or not there is an “economic activity” 
is a deceptively simple question, so has received varying responses over time and across 
different healthcare systems. 
The trigger effect of the “undertaking” concept on competition law within the healthcare 




















Figure 1: Overview of the operation of the “undertaking” concept within EU competition 
law and state aid rules. 
The above diagram suggests that – regarding the “undertaking” concept – there are two ways 
in which activities in healthcare may be deemed immune from the competition rules. Firstly, 
by finding that the activity is not “economic” in nature (thus competition rules do not apply 
at all), and secondly, by finding that, although the activity is indeed “economic”, its classification 
as an SGEI means that it is treated as an exception, thus partly immune from the competition 
rules. Although our focus here is on the former, the latter can form an important exception 
mechanism in the healthcare context (see also Sauter 2013), because the SGEI concept entails 
balancing competition concerns and public interest values. 
EU-level case law regarding healthcare has considered both “routes” to competition law 
immunity to varying degrees. As healthcare systems experiment more with private sector 
delivery of healthcare, or combined public and private arrangements, a tendency towards the 
“SGEI route” may be anticipated, insofar as this may reflect more easily the reality of 
healthcare provision and purchasing involving both “economic” and “non-economic” activities.  
It has been considered that the “contours” of the EU’s approach regarding state aid are clearer 
than regarding competition law sensu strictu - i.e. the “antitrust rules” (Hancher and Sauter 
2012). This is perhaps unsurprising if it is considered that there is greater scope for EU-level 
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intervention regarding state aid than activities which would fall within the purview of the 
antitrust rules.  
Certainly the state aid rules may have wider implications for healthcare system design and 
government reform. An example is the classification of the Dutch risk equalisation scheme to 
ensure universal access as SGEI: universal access has been considered to form a “core” around 
which the Dutch competition reforms developed (Guy 2019). However, the effect of EU 
decisions in antitrust cases have also helped shape national reforms – as evidenced by the 
introduction of Article 122 Dutch Health Insurance Act 2006 to allow application of Dutch 
competition law to Dutch private health insurers, where the CJEU AOK Bundesverband 
judgment (Joined Cases C-264/01, C-306/01, C-354/01 and C-355/01, AOK Bundesverband 
and Others) suggests that EU competition law may not apply (van de Gronden and Szyszczak 
2014). 
 
 2.1 The “abstract” and “concrete” tests in the case law 
What has also emerged from the case law regarding the “undertaking” concept is the 
categorisation of analysis as an “abstract” test and a “concrete” test (van de Gronden 2004).  
The “abstract” test is applied in the majority of the cases. The core question for qualifying an 
activity is whether the service or good at hand can potentially be supplied on the market, or 
can only be offered through the official authority of the State. The legal design of the supply 
of this service or good does not matter. If the activity under review cannot be performed 
without State intervention, it is not of an economic nature. In contrast, if the activity can 
potentially be carried out by providers on the market, it is of an economic nature irrespective 
of the fact whether its actual performance is in the hands of a State body. In other words, the 
test is performed wholly in the abstract, without reference to the national legal framework 
concerned. (van de Gronden 2018) Broadly speaking, the abstract test has been applied to 
healthcare providers, such as hospitals and physicians, and concerns the entities providing 
treatment as well as related services and goods to patients. This is logical: an “economic 
activity” is defined as “offering goods or services on a market”, which clearly references the 
activity of providing (such as supplying medical products and providing medical services), as 
distinct from purchasing. Thus, in a healthcare context, self-employed medical specialists who 
receive financial remuneration and bear financial risks in exercising their profession have been 
deemed “undertakings” (Joined Cases C-180/98 to C-184/98 Pavlov), as have standard and 
emergency patient transport services since – in a similar logic – these are provided for 
remuneration,  thus do not have to be provided by public bodies. 
In contrast, the “concrete” test is only applied in cases concerning social security systems, 
including healthcare schemes (van de Gronden 2018: pp. 203- 204). In this test, strikingly, the 
national legal framework is the starting-point. The review to be carried out revolves around 
the actual set-up of a social security scheme by a particular Member State and focuses on the 
bodies managing the scheme at hand. As a result, at the heart of the “concrete” test are 
organisations entrusted with the task of financing the social security schemes. If such a scheme 
is predominately solidarity-based, the body managing this is not engaged in an economic 
activity and does not, accordingly, qualify as an “undertaking” (Joined Cases C-159/91 and C-
160/91 Poucet). The “concrete” test is not applied in the abstract of the applicable national 
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legal framework but, on the contrary, in close connection with this framework. It considers 
the national legal framework as a decisive factor in whether or not EU competition law applies 
(van de Gronden 2018 and 2004, Baquero Cruz 2005).  
In healthcare the “abstract” and “concrete” tests have resulted in a striking outcome in CJEU 
case law. The CJEU has consistently held that healthcare providers are undertakings and 
subject to EU competition law, irrespective of the national framework they operate in 
(whether an insurance-based or taxation-funded healthcare system). Conversely, managing 
bodies in either system type may escape these rules if the schemes at issue are predominately 
solidarity-based. As a result, in some national systems, the healthcare providers must observe 
EU competition law when entering into contractual relationships with managing bodies, 
although the latter are not bound by these rules. Furthermore, financing of such managing 
bodies by the State does not give rise to issues under the EU state aid rules, while the financial 
support given to the healthcare providers in the same system could be illegal under these 
rules. As the “concrete” test merits a detailed analysis of the healthcare scheme under review, 
we examine below how this test has played out in the national healthcare systems – both 
insurance-based and taxation-funded – in the case law. 
2.2. The “concrete” test in insurance-based systems – AOK Bundesverband 
and DZP/UZP 
AOK Bundesverband considered the compatibility of EU antitrust rules with German 
statutory provisions governing the collective determination by leading sickness fund 
associations of maximum amounts paid by sickness funds towards the cost of various medicinal 
products. The question of compatibility arose in challenges brought by pharmaceutical 
companies seeking compensation for losses suffered following the introduction of maximum 
fixed amounts.  
In essence, at issue was whether German sickness funds were “undertakings” for the purposes 
of the anticompetitive agreements prohibition when they jointly determine the applicable level 
of uniform fixed amounts for medicinal products.  
The CJEU found that sickness funds in the German statutory health insurance scheme were 
not “undertakings”. This was because their involvement in managing the social security system 
meant that they fulfilled an exclusively social function, which was founded on the principle of 
national solidarity and was entirely non-profit-making (AOK Bundesverband, para 51) a logic 
built on the earlier cases of Poucet and Cisal (C-218/00, Cisal). A further justification for this 
finding was that German law required the sickness funds to offer their members essentially 
identical benefits independent of the amount of contributions. This meant that the sickness 
funds had no possibility of influencing those benefits (AOK Bundesverband, para 52) and so 
were not in competition with one another or with private institutions vis-à-vis the grant of 
obligatory statutory benefits regarding treatment or medicinal products.  
DZP/UZP was concerned with the coexistence of public and private bodies in the Slovak 
health insurance system, in which citizens choose between the state insurance provider and 
private insurance companies for compulsory health insurance. The private insurance 
companies alleged a breach of the state aid rules by the Slovak government making payments 
to the state health insurer linked with healthcare and health insurance reforms. The 
Commission considered that the measures did not constitute state aid because the 
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organisation of compulsory health insurance in the Slovak Republic could not be regarded as 
an “economic activity”. As a result, the state and private health insurers could not be classified 
as “undertakings” within the meaning of the state aid rules (DZP/UZP, para 21). The private 
health insurance companies appealed this decision on two grounds. Firstly, that the 
Commission erred in law by interpreting the “undertaking” concept too narrowly by limiting 
its review to the public and private health insurers’ activity to the single compulsory health 
insurance system and not their activities beyond this. Secondly, that the Commission made 
errors of law and assessment in finding that the public and private health insurers were not 
engaged in economic activities.  
The General Court’s judgment in DZP/UZP drew on previous case law, including AOK 
Bundesverband, in defining the parameters of its considerations, such as no direct link 
between contributions paid and benefits received, compulsory and identical benefits for all 
insured persons, contributions proportional to income, application of the pay-as-you-go 
principle, and the impossibility for health insurance bodies to influence the nature and level of 
benefits set by law or the amount of the contributions paid by the insured persons (DZP/UZP, 
paras 52-3). In light of these factors, the conclusion that the insurers were not engaged in 
economic activities appeared justified, as the Slovak system was solidarity-driven. 
Nevertheless, the General Court did eventually find that the Slovak healthcare system was of 
an economic nature. 
The General Court established the existence of an economic activity based on two factors 
(DZP/UZP, paras 62-66). Firstly, the health insurance companies’ profit-making ability, since 
they were clearly pursuing financial gains, as the Slovak health laws permitted them to use and 
distribute profits. Secondly, while the health insurance bodies were not free to determine the 
amount of contributions or formally compete via tariffs, Slovak legislation nevertheless 
introduced an element of competition on quality. This took the form of the insurers’ freedom 
to supplement compulsory statutory services with related free services, such as better 
coverage for certain complementary and preventive treatments, or an enhanced assistance 
service for insured persons (DZP/UZP, para 66). 
Overall, the General Court concluded that the activity of providing compulsory health 
insurance in Slovakia is economic in nature (DZP/UZP, para 68). This is a striking finding 
because it focuses on the insurers’ profit-making ability and a wider definition of “competition” 
which includes quality as well as price. The General Court held that not-for-profit operators 
must ‘by contagion’ be considered to be an undertaking, if other companies they compete 
with do seek to make a profit (DZP/UZP, para 69). Although such considerations were absent 
in AOK Bundesverband, they featured in the aforementioned Commission Decision in the 
Dutch health insurance state aid case, and in other, non-healthcare-related cases (e.g. Case 
C-49/07 MOTOE, para 27). 
Following the General Court’s judgment, the Commission and the Slovak Republic have 
appealed to the CJEU, suggesting that the General Court committed an error of law by 
misinterpreting the notion of “undertaking” within the meaning of the state aid rules. In 
particular, the Commission appeared to take issue with the General Court finding “that the 
mere presence of for-profit insurers in Slovakia transform the state insurers by contagion into 
undertakings within the meaning of the [state aid rules]” (C231/15 Official Journal of the 
European Union 2.7.2018), and how it uses this to disregard previous case law which 
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established that “a health insurance scheme that is predominantly solidarity-based and whose 
economic features were introduced to ensure the continuity of the scheme and the 
attainment of the social and solidarity objectives underpinning it is non-economic in nature…”. 
It is striking to note that the Commission had previously found that the Dutch healthcare 
system includes solidarity features such as open enrolment and community rating, but 
nevertheless considered that Dutch insurance companies engaged in economic activities 
because they were allowed to seek profit (Cases N541/2004 and N542/2004 para 3.1). 
It is to be hoped that the CJEU and Advocates General engage with this ground of appeal in 
particular and offer further clarity about what might be considered a “tipping point” in 
determining applicability of competition law: whether or not economic features introduced 
to ensure continuity of schemes underpinned by social and solidarity objectives do not detract 
from the solidarity basis (so operate as a means to the end of providing a solidarity-based 
healthcare system) or fundamentally change this (thus represent an end in themselves in the 
form of a system change).  
2.4. The “concrete” test in taxation-funded systems – FENIN  
Thus far, a single case has considered the applicability of EU competition law in a taxation-
funded system. FENIN (Case C-205/03/P FENIN) involved an eponymous association of 
companies supplying medical goods and equipment used in Spanish hospitals to management 
bodies of the Spanish national health service (SNS). FENIN submitted a complaint to the 
Commission alleging that the SNS management bodies abused their position as a dominant 
buyer by making systematically delayed payments. The Commission dismissed the complaint 
on the basis that the SNS management bodies’ activities vis-à-vis the public health service 
were not economic in nature, and secondly, that their capacity as purchasers could not be 
dissociated from the use made of the medical goods and equipment following their purchase. 
FENIN then appealed to the General Court, which similarly dismissed the complaint on the 
grounds that the SNS operated according to the principle of solidarity, being funded from 
social security contributions and other State funding, and providing services free of charge to 
members on the basis of universal cover (FENIN, para 8). FENIN argued that Spanish public 
hospitals sometimes also provide care for patients not covered by the SNS, such as foreign 
visitors, so charges for these. The General Court dismissed this on procedural grounds and 
effectively upheld the Commission’s finding that the SNS managing bodies were not 
undertakings subject to competition law. FENIN then appealed to the CJEU, which upheld the 
findings of the Commission and the General Court. 
The distinctive feature of the reasoning in FENIN emerges in the question of whether the 
activity of purchasing can be dissociated – or not – from the ultimate purpose of the purchase 
(to provide healthcare within a solidarity-based system). While this “dissociation” logic has 
been criticised (Sánchez Graells, 2015; Hancher and Sauter, 2012), it appears consistent with 
the definition of an “undertaking” as clearly focusing on provision rather than purchasing. 
There is also logic in examining the purpose of a purchase within a system where distinctions 
between public and private healthcare exist, such as England, where some private providers 
deliver services for National Health Service (NHS) patients, but others serve private patients 
exclusively (Guy, 2019).  
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The effect of the FENIN judgment is that it has been recognised as avoiding any (inappropriate) 
application of competition law “by the back door” (Krajewski and Farley, 2007), and as 
suggesting that the public procurement rules and state aid rules may be necessary as these 
serve to discipline the exercise of public purchasing power (Hancher and Sauter, 2012, para 
8.18, p. 230).  
It has been considered that, while the FENIN logic is freestanding, its ramifications are best 
understood when juxtaposed with the findings of the UK Competition Appeal Tribunal (CAT) 
in the contemporaneous BetterCare case (Case 1006/2/1/01, BetterCare Group Limited v 
Director General of Fair Trading) (Dunne, 2010; Sinclair, 2014). The CAT found that that the 
purchase of care home places by the Northern Irish NHS constituted an economic activity, 
and upheld the complaint of a private provider (BetterCare). This conclusion was reached by 
the CAT approaching the “undertaking” concept from an “economic, rather than a legal 
perspective”, but was nevertheless cited with approval by Advocate General Maduro in 
FENIN (Case C-205/03 P FENIN, Opinion of AG Maduro) and arguably continues to be 
regarded as good law within the UK (Sinclair, 2014).  These differing conclusions can perhaps 
be explained by the fact that the purchasing body in BetterCare was also actively engaged in 
providing services, whereas the purchasing body in FENIN was not. 
 
2.5. A “concrete” test for cases involving managing bodies: identifying 
common themes for the “undertaking” concept in healthcare? 
The broad distinction in healthcare system typology between a taxation-funded system and 
an insurance-based system can determine the scope for competition. Put simply, there is 
greater scope for competition within an insurance-based system because there is greater 
scope for demand-driven competition, as distinct from the supply-driven nature of a taxation-
funded system where governments are likely to determine the precise levels of benefits 
(Hancher and Sauter, 2012, para 8.25, p.232). Some of the reasoning within AOK 
Bundesverband, Zorgverzekeringswet, and DZP/UZP reflects this with regard to the freedom 
(or not) of health insurers to determine benefits. However, a closer look at the case law 
reveals that the distinction between tax-based and insurance-based systems is less than 
suggested. Whether there is room for competition in a system can be answered in a flexible 
way.  
To start with, there have been attempts to “square the circle” arising from the FENIN and 
BetterCare judgments by emphasising actual or potential making of profit, with even the latter 
proving sufficient to trigger applicability of EU competition law (Sinclair, 2014). Furthermore, 
while emphasis on a widened definition of “profit-making” is clearly a defining feature of the 
DZP/UZP judgment, the General Court appears to add another dimension with a widening 
of the definition of “competition” to include quality, as well as price. 
Consequently, a very sophisticated approach is being developed for determining what 
competition is. In both tax-based and insurance-based systems, profit-making and competition 
on price as well as quality can occur, thus arguments for finding the competition rules 
applicable are similar in both systems.  
It is curious that the discussions of DZP/UZP have been confined to the initial question of 
whether an undertaking exists – with no suggestion that the issue of allocating an SGEI 
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function may also be relevant. This in itself would appear to mark a departure from state aid 
cases concerning Dutch and Irish risk equalisation schemes since these function as a 
mechanism to support a solidarity- based system and have been classified as SGEI, thus 
partially immune from the competition rules. The appeal in AOK Bundesverband was framed 
as two questions: firstly, whether an undertaking existed, and secondly, whether the SGEI 
exception was relevant. It should be kept in mind that solidarity objectives could be achieved 
on competitive markets by partly allowing some restrictive practices and measures (cf. Davies, 
2010). 
All in all, cases dealing with managing bodies show that the levels of competition and solidarity 
are key features that must be scrutinised in order to find whether competition law applies. 
The development of additional considerations regarding these aspects in DZP/UZP 
demonstrates that the approach applied to managing bodies is more complex, in contrast to 
the simpler, “abstract” test applied to healthcare providers. In the “concrete” test, the specific 
features of healthcare schemes are closely examined: the “concrete” test, as deployed in the 
case law, allows for accommodating healthcare-specific concerns in the review and places a 
strong emphasis on solidarity, a core value in (many) national healthcare systems. Such 
considerations are absent from the “abstract” test, so no detailed analysis of the healthcare 
providers’ activities is made, nor is the role of solidarity considered. 
We consider now whether a less simple test for determining the applicability of competition 
law to healthcare providers may also be appropriate, in view of the healthcare providers’ role 
being more complicated than simply providing services for remuneration. We suggest that 
such a test may emerge from the CEPPB state aid case.  
 
3. The new three-prong test in CEPPB from a healthcare perspective: a new test 
for healthcare providers? 
It is apparent from the above analysis that so far in healthcare the discussion has focused on 
qualification of managing bodies, such as health insurance companies. Their position has given 
rise to heated debate both in case law and legal doctrine. The qualification of healthcare 
providers, as counterparts of the managing bodies in many healthcare systems, has been 
relatively neglected until now. In our view this is because the CJEU has consistently held that 
the mere fact that providers receive remuneration for their activities suffices for qualifying 
them as “undertakings”. This raises the question whether this does justice to the complex 
and significant task they perform. A common thread running through assessments under 
competition law is that a profound understanding of the economic and legal context is 
essential (Cases 96-102, 104, 105, 108 and 110/82 IAZ para 25, and Case C-8/08 T-Mobile 
para 27). The CJEU has stressed the merits of a close examination of all issues and 
circumstances at play in interpreting competition law (Case 67-13, Cartes Bancaires). In fact, 
the sophisticated approach developed towards the “undertaking” concept in cases involving 
managing bodies testifies to this. Would it be possible for the CJEU to moderate its 
straightforward approach towards healthcare providers and to incorporate in its case law 
elements that accommodate concerns and values related to these providers? In our view, 
important lessons may be learned from the CEPPB judgment, which developed important 




3.1. The test developed in the CEPPB judgment 
This case concerned tax exemptions for religious institutions in Spain. The Congregación de 
Escuelas Pías Provincia Betani (hereafter the Congregación) was refused this exemption for 
the use of its school hall. The municipal authorities argued that EU state aid rules prevented 
them from giving financial support to the Congregación. One of the questions to be addressed 
was whether the Congregación, which operated a primary school, was an “undertaking” for 
the purposes of EU competition law.  
The CJEU addressed this question by recalling its case law on free movement and educational 
systems. At the heart of this is whether a particular activity is a “service” within the meaning 
of Article 57 TFEU, which would mean that services are normally provided for remuneration. 
It is apparent from free movement and education case law that as soon as economic 
consideration is given for an individual service, the Treaty provisions on free movement apply 
(Case C-76/05, Schwarz and Gootjes-Schwarz, Case C-318/05, Commission v Germany and 
Case C-56/09, Zanotti). In contrast, if education is organised in a collective way, the fees due 
are not considered to be payment in exchange for services rendered, so the EU free 
movement rules do not apply (Case 263/86 Humbel and Case C-109/92, Wirth). This 
approach comes down to verifying whether an educational institution is predominately 
financed by the State or by private means. If State financing is dominant, the educational 
activities are not of an economic nature, whereas a prominent role of private financing 
suggests that educational services are economic.  
In CEPPB the CJEU recycled this free movement case law in order to address the question as 
to whether the Congregación was an undertaking when operating a school and offering 
services closely related to this. It was held that a school predominately financed by the State, 
fulfilling its social, cultural and educational duties towards the population, is not an 
“undertaking”. By contrast, educational services do constitute economic activities if they are 
financed by private funds (students, parents or other private players). Consequently, the 
approach adopted in CEPPB in order to qualify an activity under the competition rules was 
identical to that developed in EU free movement cases. Furthermore, the CJEU pointed out 
that an entity could be engaged in both economic and non-economic activities. In other words, 
although the operation of a primary school is likely to be non-economic, the use of the school 
hall for activities, such as offering private courses, can definitely be of an economic nature. In 
such circumstances, an entity must be severed in two parts. 
The emphasis put on the level of the public financing reveals that State involvement is one of 
the key elements in establishing whether an educational institution is an “undertaking”. This 
involvement underlines the collective organisation of the educational system. No individual 
services are provided to specific persons; rather, it is guaranteed that a collective group of 
citizens is granted access to education. This means that the supply of services concerned is 
dependent on State intervention. Without public funding these services are not supplied. In 
contrast, some educational services, such as after-school tutoring, could be provided to 
specific persons in return for remuneration. Consequently, the mere existence of public 
funding does not suffice for carving out particular activities from the scope of EU competition 
law. The question to be answered is whether the supply of a service or a good can only be 
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guaranteed through public funding. In other words, taxpayers’ money is needed to provide 
these services and goods for the public benefit. This means that solidarity is the principle 
underpinning the State intervention by means of public funding, as through taxation, wealth is 
redistributed in order to guarantee access for all to essential services. Concerns of solidarity 
justify that, in some cases, the competition rules do not limit the room for manoeuvre for 
Member States when organising their welfare schemes, including national healthcare systems 
(Ross, 2010)  
If this is true, the CJEU’s decision in CEPPB sheds new light on the issue as to whether 
healthcare providers must be regarded as “undertakings”. Above, it was pointed out that the 
principle of solidarity is one of the key elements for qualifying bodies managing social security 
systems, including healthcare schemes, as “undertakings”. In fact, the prominent role of 
solidarity prevents these bodies from being qualified as “undertakings”. The characteristics of 
the activities concerned does not justify market forces playing a role. In the same vein, it could 
be argued that some health services are provided in a solidarity-driven framework, which 
makes it problematic to accommodate market dynamics in their supply. In fact, inherent in 
the assessment carried out in CEPPB, which concerned the provision of educational services, 
is the principle of solidarity. 
Allowing consideration of solidarity-based concerns in the assessment under the competition 
rules would imply the “undertaking” concept must be (slightly) moderated. Admittedly, the 
“concrete” test is specifically developed for striking a balance between EU competition law 
and social security. The status of healthcare providers is assessed in accordance with the 
“abstract” test. In our view, however, solidarity is also an important element in the “abstract” 
test. As noted above, the exercise of official authority does not amount to an economic 
activity because this kind of State involvement is closely related to solidarity-based values: if 
there is no market, it does not make sense to apply the competition rules. Market players are 
not capable of delivering certain ‘public goods’, and so the State carries out certain tasks, such 
as policing, or issuing passports. In the same vein, some health services cannot be provided 
without public funding. In the public benefit the State finances the provision of the services 
that cannot be provided in the marketplace. 
Which test must be carried out in order to determine whether a certain healthcare provider 
is an “undertaking” for the purposes of competition law? It is clear from the approach 
developed by the CJEU in CEPPB that the first condition requires the supply of the services 
by a certain provider to be mainly dependent on State funding. Furthermore, given the role 
of solidarity, the second condition is that the funding is geared towards achieving a public 
interest objective: accordingly, financial State intervention is necessary. As a close relationship 
should exist between the public interest objective and the public funding, the third condition 
is that the healthcare provider’s activities are closely related to this objective. In other words, 
when it comes to healthcare providers, our proposal is to carry out the following three-prong 
test (van de Gronden, 2018) comprising cumulative (not alternative) elements:  
1) the supply of the services or goods of these providers is mainly dependent on public funding;  
2) the aim of this funding is the attainment of an objective of public interest; and  
3) the activities concerned are closely related to this objective. 
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It is clear from the outset that the second and third conditions relate to solidarity. The State 
intervenes in order to make the supply of services and goods available for its citizens. The 
first condition of the test, however, merits further clarification. It cannot be excluded with 
regard to cost-intensive services and goods that some end-users are prepared to pay a high 
sum of money for e.g. highly-specialised medical treatment. However, this does not mean in 
itself that such services or goods can be offered on the market by economically viable 
companies. This depends on the expenses incurred by the operators in the supply and the 
number of customers willing to spend the great sum of money needed. If these expenses are 
very high and only a limited number of customers can make purchases, the services or goods 
concerned cannot be offered viably given the ‘lack of critical mass on the demand side’. In 
other words, in these circumstances no real business case exists for enterprises supplying the 
services and goods concerned. Given the characteristics of these services or goods, the 
majority of customers cannot afford to purchase them and consequently, collective funding is 



















































Figure 2: Overview of the possible operation of the “undertaking” concept regarding 
healthcare providers in light of the CEPPB test. 
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A clear example of healthcare provision falling outside the scope of competition law is offered 
by certain types of specialist treatment. For example, where certain types of specialist 
treatment can only be provided to citizens because of public funding, the first condition is 
likely to be satisfied. The expenses for such treatment are so massive that only a very small 
group of patients can afford this, which entails that no real business case exists for commercial 
operators. Taxpayers’ money is, therefore, required and, accordingly, State intervention based 
on solidarity is justified (van de Gronden, 2018).  The second criterion is satisfied by the 
existence of the objective being set out in national legislation (for example, to ensure public 
health), and the third by demonstrating a close connection between the activity (provision of 
certain specialist healthcare services) and the public interest objective. As regards the second 
and third criteria, the State funding is based on solidarity, i.e., the rationale of this intervention 
lies in the need to provide universal access to the medical treatment concerned. 
In this regard it must be noted that an assessment based on the three-prong test could result 
in a part of the activities of a healthcare provider being considered economic and a part not. 
In that case this entity must be severed in two parts: one falling within the scope of the 
competition rules, and one falling outside. Thus, a hospital offering certain types of specialist 
treatment is not an “undertaking” for these purposes, but is engaged in economic activities 
when providing ‘regular’ medical services. 
In our view, one of the advantages of the CEPPB test is that it allows due consideration of 
specific characteristics of the services of a healthcare provider. Rather than assuming that the 
exchange of payment for a service triggers the applicability of the competition rules 
(irrespective of the nature of this service), exploring the content and the financing of a 
healthcare service, including aspects of solidarity, should be decisive for establishing whether 
EU competition law applies. In our view, this would do justice to complex problems 
surrounding the provision of healthcare services. Ultimately, deciding on the applicability of 
the competition rules means asking whether the healthcare providers can operate on a 
genuine market. 
3.2. The CEPPB three-prong test in healthcare: a Dutch case study 
An interesting example of how the CEPPB test could work arises from a recent Dutch case 
about financing Non-Invasive Pre-natal Tests (NIPTs) (Gendia v Dutch Ministry of Health, 
Wellbeing and Sport). 
At issue was a subsidy given by the Dutch government to a consortium including academic 
hospitals for offering the NIPT to every pregnant woman and her partner in order to detect 
Downs, Edwards and Patau syndromes. A Belgian company, Gendia, took the view that this 
subsidy was not in line with the EU state aid rules. Gendia claimed to be able to provide the 
NIPT to Dutch women at a price of €590, but Dutch academic hospitals could charge a fee 
of €175. Charging this lower fee was one of the conditions attached to the Dutch government 
subsidy. The Dutch appeal court found that the offering of a NIPT was designated as a SGEI 
in Dutch health law and financing this was, therefore, compatible with the state aid rules (OJ 
2012 L7/3). Interestingly, the appeal court held that the market was not capable of offering 
the NIPT service in combination with counselling to all at affordable prices. In our view, it 
could have examined whether the services (NIPT test and counselling) offered were 
predominately dependent on public funding, as no viable business case existed for commercial 
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service provision. If so, the court could have ruled that offering NIPTs to (a wide range of) 
pregnant women does not amount to economic activities and for that reason the state aid 
rules were not violated. The consequence of this approach is that the aid given does not need 
to be compatible with the specific conditions for SGEI set out in EU law. It should be noted 
that the Dutch court referred to the Commission’s SGEI Communication, which provides 
that an SGEI mission may not be assigned to operators if the market already provides, or can 
provide satisfactorily, the services in question (OJ 2012 C8/4, para 48). In our view a 
distinction must be made between services that cannot viably be provided by the market, and 
services that cannot satisfactorily be provided by the market (consistent with the public 
interest). The first group of services is non-economic, whereas the second group has an 
economic dimension. 
Furthermore, the Dutch Authority for Consumers and Markets (ACM) has taken the view in 
its guidance (ACM 2010) that healthcare provides are engaged in economic activities, as they 
offer services, such as medical treatment, nursing care as well as laboratory and x-rays for 
other physicians, in exchange for payment. The ACM could reconsider its view on the 
“undertaking” concept in healthcare cases by paying attention to the CEPPB test. It could 
accommodate considerations related to the role of public funding by asking whether some 
specialist health services are provided for the sole reason that the State finances these 
services. In that case, no market exists and so it does not make sense to apply competition 
law, which constitutes the rules of the game for the market. The services rendered must be 
organised in a collective way, which does not justify the application of competition law. 
4. Conclusions 
In the case law on the “undertaking” concept and managing bodies much attention is paid to 
the healthcare-specific circumstances under which these bodies operate. Key issues are the 
level of competition and the role of solidarity. This case law has resulted in a sophisticated 
“concrete” test, which continues to give rise to legal debate and litigation at national and EU 
level. Nevertheless, healthcare-specific concerns are accommodated in the reviews in this 
test. To date those concerns do not play a role in cases concerning the “undertaking” concept 
and healthcare providers. In these cases, an “abstract” test is applied focusing mainly on 
whether a service or good is supplied in exchange for payment. This does not do justice to 
the complex healthcare services provided, which could, eventually, result in application of the 
competition rules where no genuine markets exist. In this paper we have proposed addressing 
this problem by applying a three-prong test to healthcare providers where: 1) the supply of 
the services or goods is mainly dependent on public funding; 2) the aim of this funding is the 
attainment of an objective of public interest; and 3) the activities concerned are closely related 
to this objective. This test pays due consideration to the specific features of the healthcare 
services and goods concerned. It should be noted that the test is still “abstract” as it takes 
potential competition as its starting-point: only if no viable business case exists, do the 
competition rules not apply. One of the core questions in this test is whether the market is 
capable of providing the services or goods under review. Whether this is the case may change 
over time. New technologies could make it possible that the costs incurred in providing 
services that were very cost-intensive at first decrease (massively). The emergence of ICT, 
such as techniques based on big data, is an example of this. In these circumstances the services 
concerned can be provided on the market and are, accordingly, transformed from non-
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economic into economic activities, prompting the applicability of competition law. This does 
not, however, question the importance of solidarity. In order to strike the right balance 
between market forces and solidarity, deference must be made to the SGEI concept. 
Accordingly, the SGEI concept will remain an important alternative for achieving solidarity-
based objectives in healthcare.  
---------------------- 
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